Inflammation: Part 1: History
Please note this is an old version of this entry, which may differ significantly from the current revision.
Contributor:

Inflammation, a vital and intricately regulated biological response, defends the body against threats like pathogens and injuries. When balanced, it supports health, but disruption can lead to chronic inflammation and diseases like cardiovascular issues and cancer. This exploration delves into inflammation's mechanisms, involving lipid-derived mediators, proinflammatory cytokines, vasoactive mediators, hydrolytic enzymes, reactive oxygen species, transcription factors, and the complement system. Understanding these elements is crucial for targeted therapies against inflammation-related diseases. Researchers continually uncover innovative strategies to restore the balance between protective and pathological inflammation, offering hope to millions with chronic inflammatory conditions. Advancements promise more effective management, a brighter future, and improved lives.

  • inflammation
  • Lipid-Derived Mediators
  • Proinflammatory Cytokines
  • Vasoactive Mediators
  • Hydrolytic Enzymes
  • Reactive Oxygen Species
  • Complement System

1. Introduction

Inflammation, a fundamental biological response, stands as the body's intricate defense mechanism against a plethora of threats, ranging from pathogens and tissue injuries to irritants. When properly regulated, this dynamic process plays a pivotal role in safeguarding the body, eliminating threats, and fostering tissue repair. However, the delicate equilibrium of inflammation can be disrupted, resulting in the emergence of chronic inflammation or an exaggerated immune response. These imbalances can, in turn, precipitate a wide spectrum of diseases, encompassing cardiovascular disorders, autoimmune conditions, and cancer.

This entry embarks on an enlightening journey into the realm of inflammation, aiming to unravel the central actors and mechanisms that orchestrate this complex biological phenomenon. By delving into the intricacies of lipid-derived mediators, proinflammatory cytokines, vasoactive mediators, hydrolytic enzymes, reactive oxygen species, transcription factors, and the complement system, we endeavor to gain a comprehensive understanding of how inflammation unfolds and impacts the body. This knowledge is pivotal in the quest to develop precise and targeted therapies to effectively manage inflammation-related diseases, offering hope and relief to the millions of individuals affected by chronic inflammatory conditions worldwide.

2. Lipid-Derived Mediators

Arachidonic acid serves as a central player in the inflammatory response, acting as a precursor to eicosanoids, a family of lipid-derived mediators. Among these, prostaglandins and leukotrienes play pivotal roles in regulating various inflammatory processes. Prostaglandins are known for their bronchoconstrictive effects, vasodilation, and increased vascular permeability [1]. Inhibiting 5-lipoxygenase, an enzyme responsible for leukotriene production, shows promise in treating inflammatory skin conditions like dermatitis and psoriasis [2]. Additionally, platelet-activating factor, generated by inflammatory cells, contributes to bronchoconstriction, platelet activation, and chemotaxis, further amplifying the inflammatory response [3].

3. Proinflammatory Cytokines

Cytokines, a diverse class of signaling molecules, play a central role in regulating immune responses and inflammation. Tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) are proinflammatory cytokines released by monocytes and macrophages. TNF-α, in particular, is implicated in the pathology of rheumatoid arthritis and cancer metastasis [4]. IL-1β not only activates lymphocytes but also promotes bone resorption[5]. These cytokines not only regulate immune cell functions but also govern processes like adhesion molecule expression, cell growth, apoptosis, immunoglobulin production, and chemotaxis in target cells [3]. Understanding their precise roles is crucial for developing therapies targeting specific inflammatory pathways [6].

4. Vasoactive Mediators

Histamine, stored primarily in mast cells and basophil leukocytes, is a widely distributed and preformed proinflammatory mediator. Upon release, histamine causes a transient increase in permeability following tissue injury, allowing the passage of fluids and proteins through inter-endothelial junctions [7]. Histamine also induces endothelial cell contraction and edema formation while enhancing gastric acid secretion [3]. Serotonin, another vasoactive amine found in various tissues, contributes to increased vascular permeability and smooth muscle contraction [7]. Additionally, bradykinin promotes endothelial cell separation, gap formation in post-capillary venules, and augmented vascular permeability [7]. The interplay of these vasoactive mediators orchestrates early vascular changes during the inflammatory response, shaping its trajectory [8].

5. Hydrolytic Enzymes

Proinflammatory cells release a cadre of hydrolytic enzymes during inflammation. One such enzyme, human leukocyte elastase (HLE), is central to elastin hydrolysis and the migration of stimulated proinflammatory mediators [3]. Elastin, a primary component of elastic fibers in blood vessels and lungs, is crucial for maintaining tissue integrity. The release of HLE can lead to the breakdown of elastin, contributing to tissue damage and the perpetuation of inflammation [3]. The release of hydrolytic enzymes, particularly human leukocyte elastase (HLE), constitutes a pivotal yet potentially detrimental aspect of the inflammatory response.

6. Reactive Oxygen Species (ROS)

Inflammation and oxidative stress are closely intertwined in various pathophysiological events. Reactive oxygen species (ROS) play a pivotal role in cellular defense mechanisms, but their overproduction can exacerbate oxidative stress and promote the expression of proinflammatory genes [9][10][11]. ROS can initiate intracellular signaling pathways and affect proinflammatory gene expression, further fueling the inflammatory response [12]. The delicate balance between ROS production and the body's antioxidant defense mechanisms is critical in inflammation-related diseases.

7. Transcription Factors

Nuclear factor-kappa beta (NF-κB) stands as the chief regulator of both the immune system and the inflammatory response  [13]. It controls the transcription of genes involved in apoptosis, cell adhesion, proliferation, cellular stress response, immune response, inflammatory pathways, and tissue remodeling [13]. Genes encoding critical inflammatory cytokines such as IL-1β, IL-2, IL-6, IL-8, and TNF-α are under NF-κB's regulatory control. Various compounds, including glucocorticoids and aspirin at high doses, can modulate NF-κB activation, making this transcription factor an attractive therapeutic target for inflammatory ailments [14].

8. Complement System

Activation of the complement cascade results in the formation of anaphylatoxins, including C5a. These anaphylatoxins enhance antibody production, cytokine release, and oxidative stress, further fueling the inflammatory cascade [5]. C5a is a potent chemoattractant that recruits inflammatory cells like neutrophils, eosinophils, monocytes, and T lymphocytes to the site of inflammation [15]. By amplifying the immune response, the complement system plays a critical role in regulating inflammation and its consequences.

9. Conclusion

In conclusion, inflammation, a highly intricate and finely tuned biological response, relies on a multitude of key players, each playing a crucial role in shaping the overall outcome. A comprehensive understanding of the functions and intricate interactions among lipid-derived mediators, proinflammatory cytokines, vasoactive mediators, hydrolytic enzymes, reactive oxygen species, transcription factors, and the complement system is paramount. This comprehension forms the cornerstone for the development of targeted therapeutic strategies aimed at combatting inflammation-related diseases more effectively while minimizing unwanted side effects.

The relentless efforts of researchers continue to unravel the complexities of inflammatory mediators, unveiling novel approaches to restore the delicate balance between protective and pathological inflammation. This ongoing exploration offers a ray of hope for the millions worldwide who endure the challenges of chronic inflammatory conditions, holding the promise of improved quality of life. As our knowledge deepens and therapeutic interventions become increasingly precise, we draw closer to a future where inflammation-related diseases can be managed with greater sophistication and efficacy. This progress signifies a brighter outlook for individuals grappling with the burdens of chronic inflammation, paving the way for a healthier and more fulfilling life.

References

  1. Stables MJ, Gilroy DW. Old and new generation lipid mediators in acute inflammation and resolution. Prog Lipid Res. 2011 Jan;50(1):35-51. doi: 10.1016/j.plipres.2010.07.005. Epub 2010 Jul 23. PMID: 20655950.
  2. Schinella G., Máñez S., Ríos J.L., Prieto J.M., Giner R.M., Recio M.C. Diphyllin Acetylapioside, A 5-Lipoxygenase Inhibitor from Haplophyllum hispanicum. Planta Med. 2002;68:359–360
  3. Safayhi H., Sailer E.-R. Anti-Inflammatory Actions of Pentacyclic Triterpenes. Planta Med. 1997;63:487–493. doi: 10.1055/s-2006-957748.
  4. Cho J.Y., Yoo E.S., Baik K.U., Park M.H., Han B.H. In Vitro Inhibitory Effect of Protopanaxadiol Ginsenosides on Tumor Necrosis Factor (TNF)-α Production and its Modulation by Known TNF-α Antagonists. Planta Med. 2001;67:213–218. doi: 10.1055/s-2001-12005.
  5. Kulkarni R.G., Achaiah G., Sastry G.N. Novel targets for antiinflammatory and antiarthritic agents. Curr. Pharm. Des. 2006;12:2437–2454. doi: 10.2174/138161206777698945.
  6. Lawrence T., Willoughby D.A., Gilroy D.W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2002;2:787–795. doi: 10.1038/nri915.
  7. Larsen G.L., Henson P.M. Mediators of inflammation. Annu. Rev. Immunol. 1983;1:335–359. doi: 10.1146/annurev.iy.01.040183.002003.
  8. Hersh E.M., Bodey G.P. Leukocytic Mechanisms in Inflammation. Annu. Rev. Med. 1970;21:105–132. doi: 10.1146/annurev.me.21.020170.000541.
  9. iswas S.K. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxidative Med. Cell. Longev. 2016;2016 doi: 10.1155/2016/5698931.
  10. Anderson M.T., Staal F., Gitler C., Herzenberg L.A. Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. Proc. Natl. Acad. Sci. USA. 1994;91:11527–11531. doi: 10.1073/pnas.91.24.11527. [
  11. Flohé L., Brigelius-Flohé R., Saliou C., Traber M.G., Packer L. Redox Regulation of NF-kappa B Activation. Free. Radic. Boil. Med. 1997;22:1115–1126. doi: 10.1016/S0891-5849(96)00501-1.
  12. Biswas S.K. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxidative Med. Cell. Longev. 2016;2016 doi: 10.1155/2016/5698931.
  13. Heras B.D.L., Hortelano S. Molecular basis of the anti-inflammatory effects of terpenoids. Inflamm. Allergy-Drug Targets. 2009;8:28–39. doi: 10.2174/187152809787582534.
  14. Lee J.-H., Choi J.K., Noh M.S., Hwang B.Y., Hong Y.S., Lee J.J. Anti-inflammatory effect of kamebakaurin in in vivo animal models. Planta Med. 2004;70:526–530. doi: 10.1055/s-2004-827152.
  15. Guo R.-F., Ward P.A. role of C5A in inflammatory responses. Annu. Rev. Immunol. 2005;23:821–852. doi: 10.1146/annurev.immunol.23.021704.115835.
  16. Biswas S.K. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxidative Med. Cell. Longev. 2016;2016 doi: 10.1155/2016/5698931.
More
This entry is offline, you can click here to edit this entry!
Video Production Service